ex_img03.jpg

Translational Medicine

Furthering progress in Translational Medicine – moving from bench to bedside to turn breakthrough research discoveries into healthcare solutions – InnaVirVax is proud to collaborate with leading academic institutions.

Home_Investor.jpg

Invest for the future

InnaVirVax continuously expands its network with the primary objectives of accessing external resources, incorporating expertise and knowledge so as to optimize time to market and continuously improving its pipeline.

ex_img01.jpg

Patient

Patients are at the core of our research to improve their quality of life.

InnaVirVax

About us

InnaVirVax is a privately-owned clinical stage biotechnology company developing cutting-edge, immune-based treatments for infectious and major chronic diseases. These therapies are based on a versatile platform to enable the development of targeted vaccines.

Events
2015
September
07

InnaVirVax will be at 15th Annual Biotech Congress organized by Sachs Associates the 29th & 30th September


July
19

InnaVirVax participated in the conference International AIDS Society in Vancouver, Canada